Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

GNFT

Genfit (GNFT)

Genfit SA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GNFT
DatumZeitQuelleÜberschriftSymbolFirma
29/05/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
22/05/202418h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
14/05/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
17/01/202412h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
11/01/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
16/11/202322h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
09/11/202322h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
06/11/202313h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
05/09/202322h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
12/07/202322h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNFTGenfit SA
31/05/202322h44PR Newswire (US)Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF)NASDAQ:GNFTGenfit SA
31/05/202322h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
24/05/202321h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
11/05/202322h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
09/05/202322h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
05/05/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNFTGenfit SA
01/05/202322h01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GNFTGenfit SA
28/04/202312h17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
18/04/202319h58Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:GNFTGenfit SA
05/01/202322h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
17/11/202222h10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
10/11/202222h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
25/10/202222h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
29/09/202222h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
29/09/202214h35TipRanksH.C. Wainwright Sticks to Their Buy Rating for Genfit SA (GNFT)NASDAQ:GNFTGenfit SA
19/09/202212h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
08/07/202222h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
25/05/202222h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
29/04/202222h26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
27/04/202215h44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNFTGenfit SA
 Showing the most relevant articles for your search:NASDAQ:GNFT